Back |
home / stock / eton / eton message board
Subject | By | Source | When |
---|---|---|---|
looks like the fda did already inspect their | BioSpecialist | investorshub | 07/10/2019 4:49:07 PM |
What about the inspection? The reason the month | XXSPOWER | investorshub | 07/10/2019 4:12:49 PM |
Opaleye bought 5% stake or 881K shares of | BioSpecialist | investorshub | 07/10/2019 1:41:17 PM |
2 Days untill FDA Decision .... | BioSpecialist | investorshub | 07/09/2019 1:33:02 PM |
$9+ before FDA Decision on Thursday is possible | BioSpecialist | investorshub | 07/08/2019 7:56:03 PM |
Deals which just closed in last 6 months : | BioSpecialist | investorshub | 07/08/2019 3:15:13 PM |
First FDA Decision this Thursday ............ | BioSpecialist | investorshub | 07/08/2019 1:44:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Eton Pharmaceutcials Inc. Company Name:
ETON Stock Symbol:
NASDAQ Market:
Eton Pharmaceutcials Inc. Website:
- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 - - Product has patent protection through 2043 - DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innov...
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13 th straight quarter of sequential product sales growth • Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...